Bausch + Lomb Announces Participation in RBC Capital Markets Global Healthcare Conference

VAUGHAN, ON, May 13, 2022 /PRNewswire/ — Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better for better live, announced today that Joseph C. PapaChairman and Chief Executive Officer, is scheduled to attend the RBC Capital Markets Global Healthcare Conference on May 17, 2022to 9:30 a.m. ET.

A live webcast and audio archive of the conference calls will be available on the Investor Relations page of the Bausch + Lomb website at:

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every stage of life. Its comprehensive portfolio of over 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and sales footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with headquarters in Bridgewater, New Jersey. For more information, visit and join us on Twitter, LinkedIn, Facebook and instagram.

Bausch + Lomb (PRNewsfoto/Bausch + Lomb)



Show original content to download multimedia:–lomb–announces-participation-at-the-rbc-capital-markets-global-healthcare-conference-301546237.html

SOURCEBausch + Lomb Corporation